Style | Citing Format |
---|---|
MLA | Mirzaei H, et al.. "Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes." Journal of Diabetes and Metabolic Disorders, vol. 21, no. 1, 2022, pp. 123-131. |
APA | Mirzaei H, Siavash M, Shahnazi H, Abasi MH, Eslami AA (2022). Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes. Journal of Diabetes and Metabolic Disorders, 21(1), 123-131. |
Chicago | Mirzaei H, Siavash M, Shahnazi H, Abasi MH, Eslami AA. "Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes." Journal of Diabetes and Metabolic Disorders 21, no. 1 (2022): 123-131. |
Harvard | Mirzaei H et al. (2022) 'Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes', Journal of Diabetes and Metabolic Disorders, 21(1), pp. 123-131. |
Vancouver | Mirzaei H, Siavash M, Shahnazi H, Abasi MH, Eslami AA. Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes. Journal of Diabetes and Metabolic Disorders. 2022;21(1):123-131. |
BibTex | @article{ author = {Mirzaei H and Siavash M and Shahnazi H and Abasi MH and Eslami AA}, title = {Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {21}, number = {1}, pages = {123-131}, year = {2022} } |
RIS | TY - JOUR AU - Mirzaei H AU - Siavash M AU - Shahnazi H AU - Abasi MH AU - Eslami AA TI - Assessment of the Psychometric Properties of the Persian Version of the Diabetes Self-Management Questionnaire (Dsmq) in Patients With Type 2 Diabetes JO - Journal of Diabetes and Metabolic Disorders VL - 21 IS - 1 SP - 123 EP - 131 PY - 2022 ER - |